- Home
- BODI vs ALUR Comparison
BODI vs ALUR Comparison
Compare BODI & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- ALUR
- Stock Information
- Founded
- BODI 1998
- ALUR 2009
- Country
- BODI United States
- ALUR United States
- Employees
- BODI N/A
- ALUR 137
- Industry
- BODI Industrial Machinery/Components
- ALUR
- Sector
- BODI Industrials
- ALUR
- Exchange
- BODI Nasdaq
- ALUR Nasdaq
- Market Cap
- BODI 25.4M
- ALUR 18.0M
- IPO Year
- BODI N/A
- ALUR N/A
- Fundamental
- Price
- BODI $4.12
- ALUR $2.47
- Analyst Decision
- BODI Strong Buy
- ALUR Strong Buy
- Analyst Count
- BODI 3
- ALUR 3
- Target Price
- BODI $10.67
- ALUR $22.83
- AVG Volume (30 Days)
- BODI 92.5K
- ALUR 74.1K
- Earning Date
- BODI 08-05-2025
- ALUR 08-12-2025
- Dividend Yield
- BODI N/A
- ALUR N/A
- EPS Growth
- BODI N/A
- ALUR N/A
- EPS
- BODI N/A
- ALUR N/A
- Revenue
- BODI $371,113,000.00
- ALUR $28,304,000.00
- Revenue This Year
- BODI N/A
- ALUR N/A
- Revenue Next Year
- BODI N/A
- ALUR $49.37
- P/E Ratio
- BODI N/A
- ALUR N/A
- Revenue Growth
- BODI N/A
- ALUR N/A
- 52 Week Low
- BODI $3.38
- ALUR $2.15
- 52 Week High
- BODI $9.40
- ALUR $33.75
- Technical
- Relative Strength Index (RSI)
- BODI 54.83
- ALUR 47.19
- Support Level
- BODI $3.51
- ALUR $2.38
- Resistance Level
- BODI $4.22
- ALUR $2.54
- Average True Range (ATR)
- BODI 0.29
- ALUR 0.13
- MACD
- BODI 0.07
- ALUR -0.00
- Stochastic Oscillator
- BODI 54.50
- ALUR 42.08
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.